Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Carcinoma, Hepatocellular 6Stomach Neoplasms 4Rectal Neoplasms 4Gastro-enteropancreatic neuroendocrine tumor 4Esophageal Neoplasms 4Diarrhea 4Weight Loss 3Pancreatic Neoplasms 3Neuroendocrine Tumors 3Colonic Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Malnutrition 2Duodenal Neoplasms 2Vulvar Neoplasms 1Vomiting 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatitis 1Pancreatic Neuroendocrine Tumor G2 1Pancreatic Intraductal Neoplasms 1Nutrition Disorders 1Neoplastic Cells, Circulating 1Nausea 1Liver Neoplasms 1Intestinal Obstruction 1Insulin Resistance 1

Interventions

pembrolizumab 17Surveys and Questionnaires 12Specimen Handling 11Docetaxel 11Nivolumab 9Interviews as Topic 9Standard of Care 8Gemcitabine 8Early Intervention, Educational 8olaparib 7enzalutamide 7Magnetic Resonance Spectroscopy 7Psychiatric Rehabilitation 6Paclitaxel 6durvalumab 5Trastuzumab 5Radiotherapy 5Ipilimumab 5Carboplatin 5Bevacizumab 5pertuzumab 4palbociclib 4cabozantinib 4atezolizumab 4abiraterone 4Therapeutics 4Taxes 4Oxaliplatin 4Methods 4Immunoglobulin G 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Octreotide × Gastrointestinal × Clear all
NCT00033605 2016-07-13

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Alliance for Clinical Trials in Oncology

Phase 3 Completed
130 enrolled
GastrointestinalGenitourinaryGynecologicSarcoma

Uterine Cervical Neoplasms, Diarrhea, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡